The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Apr. 16, 2021
Applicants:

Baxter International, Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark, CH;

Inventors:

Joseph Chung Tak Wong, Williamsville, NY (US);

Sarah Elizabeth Lee, Buffalo Grove, IL (US);

Assignees:

Baxter International, Inc., Deerfield, IL (US);

Baxter Healthcare SA, Glattpark, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); A61J 1/10 (2006.01); A61J 1/14 (2023.01); A61K 47/02 (2006.01); A61L 31/06 (2006.01); A61L 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A61J 1/10 (2013.01); A61J 1/1468 (2015.05); A61K 47/02 (2013.01); A61L 31/06 (2013.01); A61L 31/14 (2013.01);
Abstract

A pharmaceutically acceptable insulin premix formulation contains about 0.1-10.0 Unit/mL of insulin for intravenous administration and preferably further contains a tonicity adjuster. The methods for making and using such formulation are also provided. The pharmaceutically acceptable insulin premix formulation may be aseptically filled into a flexible container assembly to form a pharmaceutical insulin premix product. The insulin premix product can be a sterile and ready-to-use aqueous solution for glycemic control in an individual with metabolic disorders through intravenous infusion. The insulin premix product is unexpectedly stable when freshly prepared and also during its shelf-life of storage at refrigeration temperatures of 2° C. to 5° C. for 24 months followed by additional 30 days at room temperatures of 23° C. to 27° C., even without any added preservative, any added zinc, any added surfactant or any other added stabilizing excipient.


Find Patent Forward Citations

Loading…